Track topics on Twitter Track topics that are important to you
Bacteria -- especially Gram-negative strains -- are becoming increasingly resistant to current antibiotic drugs, and the development of new classes of antibiotics has slowed. Faced with these challenges, investigators are studying the potential of combination therapy, in which two or more drugs are used together to increase or restore the efficacy of both drugs against a resistant bacterial pathogen. Now new research indicates that such synergy may work even when bacteria become resistant to colistin, which is considered a treatment agent of last resort.
Original Article: Rescuing antibiotics' effectiveness in face of drug-resistant bacteriaNEXT ARTICLE